Senator Coons highlighted the misuse of the PTAB, stating, "There is some significant misrepresentation going on about what happens at the PTAB; 18 of the 20 largest litigants are from Big Tech, who use it to invalidate properly granted patents." This underlines the disparity in patent disputes, where larger entities leverage the system to challenge smaller inventors' patents, raising questions about fairness and equity in patent law.
Senator Tillis remarked on the ongoing discussions around the Patent Eligibility Restoration Act (PERA), stating, "we feel like we're making good progress, but for the purposes of the markup, I will be withdrawing it from consideration." He suggested that external influences were trying to hamper the progress of critical patent legislation, emphasizing the need for stakeholders to participate in the process.
Coons elaborated on the delays related to the PREVAIL Act by stating, "there is now a manager's amendment to address concerns... that the standing requirement contemplated by PREVAIL might prevent generic competitors and patient advocates from using the PTAB to challenge patents." This reflects the nuanced discussions occurring in Senate regarding patent reform and the impact of proposed legislation on different stakeholders.
While discussing future steps regarding the PREVAIL Act, Coons also mentioned, "Senator Ted Cruz has amendments about making the PTAB process fairer for small and independent inventors... Senator Marsha Blackburn had also asked for more time for consideration." This highlights the collaborative approach among Senators to refine patent laws to ensure they serve all inventors, not just large corporations.
Collection
[
|
...
]